Follow-The-Filings

Security · featured owners

CRDF Cardiff Oncology Inc.

Health Care COM Equity among managers we track

CRDF (Cardiff Oncology Inc.) 13F ownership among featured managers we track. Figures are as-filed 13F, not free float.

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

SEC filings

Recent issuer filings from EDGAR · 23 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 1.01,7.01,9.01 Filing Doc
DEFA14A Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
424B5 Filing Doc
8-K 1.01,8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 7.01 Filing Doc
8-K 1.01 Filing Doc
8-K 8.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
DEFA14A Filing Doc
8-K 5.02,8.01,9.01 Filing Doc
8-K 1.01,5.02 Filing Doc
8-K 7.01,9.01 Filing Doc
10-K Filing Doc
8-K 2.01,9.01 Filing Doc
8-K 5.02,8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,8.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 11 rows shown

Filed Form Detail Links
4 Period Jul 14, 2026 · 2 forms Filing Doc
4 Period Jun 18, 2026 · 2 forms Filing Doc
4 Period Jun 11, 2026 · 5 forms Filing Doc
4 Period Apr 27, 2026 Filing Doc
4 Period Apr 6, 2026 Filing Doc
4 Period Apr 14, 2026 Filing Doc
4/A Period Apr 6, 2026 Filing Doc
4 Period Mar 31, 2026 Filing Doc
4 Period Feb 17, 2026 Filing Doc
4 Period Feb 13, 2026 Filing Doc
4 Period Jul 30, 2025 Filing Doc

Updated 3 days ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $488,000 $683,000 $593,000
Net income -$41.44M -$45.43M -$45.85M
Net margin * -8492.0% -6651.7% -7732.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $77.41M $95.05M $60.13M
Total non-current assets * $4.22M $2.14M $1.76M
Total assets $81.64M $97.19M $61.88M
Total current liabilities $10.44M $13.43M $16.39M
Total non-current liabilities * $1.46M $0.813M $0.102M
Total equity $69.74M $82.95M $45.39M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$30.89M -$37.69M -$37.92M
Cash from investing $36.2M $13.73M $1.34M
Cash from financing $0M $53.78M $2.58M
Net change in cash $5.31M $29.82M -$34M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders